[
  {
    "Index": "1",
    "Result": [
      {
        "evidence": "Recently, metformin, the most widely used first-line drug for diabetes, was found to contain a carcinogenic contaminant known as N-nitroso dimethylamine (NDMA).",
        "bel_statement": "a(CHEBI:metformin) isA a(CHEBI:drug)"
      },
      {
        "evidence": "Recently, metformin, the most widely used first-line drug for diabetes, was found to contain a carcinogenic contaminant known as N-nitroso dimethylamine (NDMA).",
        "bel_statement": "a(CHEBI:metformin) association a(CHEBI:N,N-dimethyl-4-nitrosoaniline)"
      },
      {
        "evidence": "Recently, metformin, the most widely used first-line drug for diabetes, was found to contain a carcinogenic contaminant known as N-nitroso dimethylamine (NDMA).",
        "bel_statement": "a(CHEBI:N,N-dimethyl-4-nitrosoaniline) isA a(CHEBI:impurity)"
      },
      {
        "evidence": "Moreover, newer drug classes against SGLT-2 illustrate both progress and difficulties.",
        "bel_statement": "a(CHEBI:drug) regulates p(HGNC:SLC5A2)"
      },
      {
        "evidence": "The same was true previously in the case of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.",
        "bel_statement": "a(CHEBI:glucagon-like peptide-1 receptor agonist) isA a(CHEBI:drug)"
      },
      {
        "evidence": "The same was true previously in the case of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.",
        "bel_statement": "a(CHEBI:EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor) isA a(CHEBI:drug)"
      }
    ]
  },
  {
    "Index": "2",
    "Result": []
  },
  {
    "Index": "3",
    "Result": [
      {
        "evidence": "Phosphorylation at S326 is an important regulator of HSF1 transcriptional activity.",
        "bel_statement": "p(HGNC:HSF1, pmod(Ph, Ser, 326)) increases bp(GO:\"positive regulation of DNA-templated transcription initiation\")"
      },
      {
        "evidence": "Phosphorylation at S326 is mediated by AKT1, mTOR, p38, MEK1 and DYRK2.",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Phosphorylation at S326 is mediated by AKT1, mTOR, p38, MEK1 and DYRK2.",
        "bel_statement": "act(p(HGNC:MTOR), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Phosphorylation at S326 is mediated by AKT1, mTOR, p38, MEK1 and DYRK2.",
        "bel_statement": "act(p(HGNC:MAP2K1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Phosphorylation at S326 is mediated by AKT1, mTOR, p38, MEK1 and DYRK2.",
        "bel_statement": "act(p(HGNC:DYRK2), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Here, we observed activation of HSF1 by AKT1 independently of mTOR.",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) increases act(p(HGNC:HSF1))"
      },
      {
        "evidence": "AKT2 also phosphorylated S326 of HSF1 but showed weak ability to activate HSF1.",
        "bel_statement": "act(p(HGNC:AKT2), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "AKT2 also phosphorylated S326 of HSF1 but showed weak ability to activate HSF1.",
        "bel_statement": "act(p(HGNC:AKT2), ma(GO:\"kinase activity\")) increases act(p(HGNC:HSF1))"
      },
      {
        "evidence": "Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))"
      },
      {
        "evidence": "Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))"
      },
      {
        "evidence": "Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))"
      },
      {
        "evidence": "Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.",
        "bel_statement": "p(HGNC:HSF1, pmod(Ph, Thr, 142)) increases complex(p(HGNC:HSF1), p(HGNC:HSF1), p(HGNC:HSF1))"
      },
      {
        "evidence": "Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.",
        "bel_statement": "p(HGNC:HSF1, pmod(Ph, Ser, 230)) increases bp(GO:\"positive regulation of DNA-templated transcription initiation\")"
      },
      {
        "evidence": "Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.",
        "bel_statement": "p(HGNC:HSF1, pmod(Ph, Ser, 230)) increases complex(p(HGNC:HSF1), p(HGNC:GTF2B))"
      },
      {
        "evidence": "Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.",
        "bel_statement": "p(HGNC:HSF1, pmod(Ph, Ser, 230)) increases complex(p(HGNC:HSF1), p(HGNC:CDK9))"
      },
      {
        "evidence": "Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.",
        "bel_statement": "p(HGNC:HSF1, pmod(Ph, Ser, 326)) increases complex(p(HGNC:HSF1), p(HGNC:GTF2B))"
      },
      {
        "evidence": "Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.",
        "bel_statement": "p(HGNC:HSF1, pmod(Ph, Ser, 326)) increases complex(p(HGNC:HSF1), p(HGNC:CDK9))"
      },
      {
        "evidence": "Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.",
        "bel_statement": "p(HGNC:HSF1, pmod(Ph, Thr, 527)) increases bp(GO:\"positive regulation of DNA-templated transcription initiation\")"
      },
      {
        "evidence": "Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.",
        "bel_statement": "p(HGNC:HSF1, pmod(Ph, Thr, 527)) increases complex(p(HGNC:HSF1), p(HGNC:GTF2B))"
      },
      {
        "evidence": "Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.",
        "bel_statement": "p(HGNC:HSF1, pmod(Ph, Thr, 527)) increases complex(p(HGNC:HSF1), p(HGNC:CDK9))"
      }
    ]
  },
  {
    "Index": "4",
    "Result": [
      {
        "evidence": "Consistent with our previous findings, AKT1 strongly induced HSF1 activity (Fig. 1A-C).",
        "bel_statement": "act(p(HGNC:AKT1)) increases act(p(HGNC:HSF1))"
      },
      {
        "evidence": "AKT2 promoted a significant increase in HSF1 activity, but the effect was modest while AKT3 had no significant effect on HSF1 activity (Fig. 1A-C).",
        "bel_statement": "act(p(HGNC:AKT2)) increases act(p(HGNC:HSF1))"
      },
      {
        "evidence": "AKT2 promoted a significant increase in HSF1 activity, but the effect was modest while AKT3 had no significant effect on HSF1 activity (Fig. 1A-C).",
        "bel_statement": "act(p(HGNC:AKT3)) causesNoChange act(p(HGNC:HSF1))"
      },
      {
        "evidence": "Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).",
        "bel_statement": "act(p(HGNC:AKT2), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).",
        "bel_statement": "act(p(HGNC:AKT3), ma(GO:\"kinase activity\")) causesNoChange p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      }
    ]
  },
  {
    "Index": "5",
    "Result": [
      {
        "evidence": "These results seem contradictory because AKT2 phosphorylated S326, but the level of phosphorylation far exceeded the HSF1 activity induced by AKT2 (Fig. 1A-D).",
        "bel_statement": "act(p(HGNC:AKT2)) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "AKT1 is also a well-known activator of mTOR and mTOR has been shown to phosphorylate HSF1 at S326 in response to proteotoxic stress.",
        "bel_statement": "act(p(HGNC:AKT1)) increases act(p(HGNC:MTOR))"
      },
      {
        "evidence": "AKT1 is also a well-known activator of mTOR and mTOR has been shown to phosphorylate HSF1 at S326 in response to proteotoxic stress.",
        "bel_statement": "act(p(HGNC:MTOR)) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Results indicated that rapamycin had no effect on HSF1 activity (Fig. 1F) or on S326 phosphorylation (Fig. 1G) driven by AKT1.",
        "bel_statement": "a(CHEBI:sirolimus) causesNoChange act(p(HGNC:HSF1))"
      },
      {
        "evidence": "Results indicated that rapamycin had no effect on HSF1 activity (Fig. 1F) or on S326 phosphorylation (Fig. 1G) driven by AKT1.",
        "bel_statement": "a(CHEBI:sirolimus) causesNoChange p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      }
    ]
  },
  {
    "Index": "6",
    "Result": [
      {
        "evidence": "Introduction of AKT1 was observed to promote a significant increase in trimerization, although the AKT1-driven trimerization was not as much as heat stress (Fig. 2A-B).",
        "bel_statement": "p(HGNC:AKT1) increases complex(p(HGNC:HSF1), p(HGNC:HSF1), p(HGNC:HSF1))"
      },
      {
        "evidence": "AKT2 and AKT3 promoted on minimal amounts of HSF1 trimerization (Fig. 2A-B).",
        "bel_statement": "p(HGNC:AKT2) increases complex(p(HGNC:HSF1), p(HGNC:HSF1), p(HGNC:HSF1))"
      },
      {
        "evidence": "AKT2 and AKT3 promoted on minimal amounts of HSF1 trimerization (Fig. 2A-B).",
        "bel_statement": "p(HGNC:AKT3) increases complex(p(HGNC:HSF1), p(HGNC:HSF1), p(HGNC:HSF1))"
      },
      {
        "evidence": "Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).",
        "bel_statement": "p(HGNC:AKT1) increases complex(p(HGNC:HSF1), p(HGNC:HSPA1A))"
      },
      {
        "evidence": "Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).",
        "bel_statement": "p(HGNC:AKT1) increases complex(p(HGNC:HSF1), p(HGNC:HSPA8))"
      },
      {
        "evidence": "Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).",
        "bel_statement": "p(HGNC:AKT1) increases complex(p(HGNC:HSF1), p(HGNC:HSPD1))"
      },
      {
        "evidence": "Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).",
        "bel_statement": "p(HGNC:AKT2) causesNoChange complex(p(HGNC:HSF1), p(HGNC:HSPA1A))"
      },
      {
        "evidence": "Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).",
        "bel_statement": "p(HGNC:AKT2) causesNoChange complex(p(HGNC:HSF1), p(HGNC:HSPA8))"
      },
      {
        "evidence": "Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).",
        "bel_statement": "p(HGNC:AKT2) causesNoChange complex(p(HGNC:HSF1), p(HGNC:HSPD1))"
      },
      {
        "evidence": "Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).",
        "bel_statement": "p(HGNC:AKT3) causesNoChange complex(p(HGNC:HSF1), p(HGNC:HSPA1A))"
      },
      {
        "evidence": "Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).",
        "bel_statement": "p(HGNC:AKT3) causesNoChange complex(p(HGNC:HSF1), p(HGNC:HSPA8))"
      },
      {
        "evidence": "Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).",
        "bel_statement": "p(HGNC:AKT3) causesNoChange complex(p(HGNC:HSF1), p(HGNC:HSPD1))"
      },
      {
        "evidence": "Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",
        "bel_statement": "p(HGNC:AKT1) increases p(HGNC:HSPA1A)"
      },
      {
        "evidence": "These results indicate that AKT1 is the primary AKT isoform capable of activating HSF1 with AKT2 having modest effects in cells.",
        "bel_statement": "p(HGNC:AKT1) increases act(p(HGNC:HSF1))"
      }
    ]
  },
  {
    "Index": "7",
    "Result": [
      {
        "evidence": "We hypothesized that tripterine inhibits endogenous peroxynitrite formation and thereby prevents endothelial barrier dysfunction",
        "bel_statement": "a(CHEBI:celastrol) decreases a(CHEBI:peroxynitrite)"
      }
    ]
  },
  {
    "Index": "8",
    "Result": []
  },
  {
    "Index": "9",
    "Result": [
      {
        "evidence": "The second phase, excision of a short DNA strand segment containing the lesion, is carried out by an assembly of the XPG and XPF:excision repair cross-complementing 1 (ERCC1) endonucleases, together with XPA, RPA, TFIIH, and PCNA (which can bind XPG).",
        "bel_statement": "complex(p(HGNC:ERCC5), p(HGNC:ERCC4), p(HGNC:ERCC1), p(HGNC:XPA), p(FPLX:RPA), p(HGNC:GTF2H3), p(HGNC:PCNA))"
      },
      {
        "evidence": "The second phase, excision of a short DNA strand segment containing the lesion, is carried out by an assembly of the XPG and XPF:excision repair cross-complementing 1 (ERCC1) endonucleases, together with XPA, RPA, TFIIH, and PCNA (which can bind XPG).",
        "bel_statement": "complex(p(HGNC:PCNA), p(HGNC:ERCC5))"
      },
      {
        "evidence": "This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.",
        "bel_statement": "complex(p(FPLX:RPA), a(CHEBI:single-stranded DNA))"
      },
      {
        "evidence": "This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.",
        "bel_statement": "complex(p(FPLX:RPA), p(HGNC:ERCC5))"
      },
      {
        "evidence": "This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.",
        "bel_statement": "complex(p(FPLX:RPA), p(HGNC:ERCC4), p(HGNC:ERCC1))"
      },
      {
        "evidence": "This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.",
        "bel_statement": "complex(p(FPLX:RPA), p(HGNC:XPA))"
      },
      {
        "evidence": "In going from the recognition to the excision phase, the molecular assembly rearranges as XPC:HR23B is replaced by XPG.",
        "bel_statement": "p(HGNC:ERCC5) directlyDecreases complex(p(HGNC:XPC), p(HGNC:RAD23B))"
      }
    ]
  },
  {
    "Index": "10",
    "Result": []
  },
  {
    "Index": "11",
    "Result": [
      {
        "evidence": "Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.",
        "bel_statement": "act(p(HGNC:DYRK1A)) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 522))"
      },
      {
        "evidence": "Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.",
        "bel_statement": "act(p(HGNC:DYRK3)) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 522))"
      },
      {
        "evidence": "Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.",
        "bel_statement": "p(HGNC:SIRT1, pmod(Ph, Thr, 522)) increases act(p(HGNC:SIRT1))"
      },
      {
        "evidence": "AMPK phosphorylates human SIRT1 at T344 inhibiting its ability to decacetylate p53, a known target of SIRT1.",
        "bel_statement": "act(p(FPLX:AMPK)) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 344))"
      },
      {
        "evidence": "AMPK phosphorylates human SIRT1 at T344 inhibiting its ability to decacetylate p53, a known target of SIRT1.",
        "bel_statement": "p(HGNC:SIRT1, pmod(Ph, Thr, 344)) decreases act(p(HGNC:SIRT1))"
      },
      {
        "evidence": "In addition to phosphorylation, methylation of SIRT1 by Set7/9 at K233, K235, K236, and K238 inhibits the SIRT1-mediated deacetylation of p53 in response to DNA damage.",
        "bel_statement": "p(HGNC:SETD7) directlyIncreases p(HGNC:SIRT1, pmod(Me, Lys, 233), pmod(Me, Lys, 235), pmod(Me, Lys, 236), pmod(Me, Lys, 238))"
      },
      {
        "evidence": "In addition to phosphorylation, methylation of SIRT1 by Set7/9 at K233, K235, K236, and K238 inhibits the SIRT1-mediated deacetylation of p53 in response to DNA damage.",
        "bel_statement": "p(HGNC:SIRT1, pmod(Me, Lys, 233), pmod(Me, Lys, 235), pmod(Me, Lys, 236), pmod(Me, Lys, 238)) decreases act(p(HGNC:SIRT1))"
      },
      {
        "evidence": "Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.",
        "bel_statement": "p(HGNC:SUMO1) directlyIncreases p(HGNC:SIRT1, pmod(Sumo, Lys, 734))"
      },
      {
        "evidence": "Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.",
        "bel_statement": "p(HGNC:SIRT1, pmod(Sumo, Lys, 734)) increases act(p(HGNC:SIRT1))"
      },
      {
        "evidence": "Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.",
        "bel_statement": "act(p(HGNC:SENP1)) directlyDecreases act(p(HGNC:SIRT1))"
      },
      {
        "evidence": "In this study, genotoxic stress promoted the association of SIRT1 with SENP1, which may help to inhibit the ability of SIRT1 to promote survival.",
        "bel_statement": "p(HGNC:SIRT1) association p(HGNC:SENP1)"
      },
      {
        "evidence": "Additionally, transnitrosylation of SIRT1 by GAPDH at C387 and C390 has been found to inhibit the activity of SIRT1 leading to decreased PGC1\u0003b1 transcriptional activity; PGC1\u0003b1 is an important regulator of metabolism and mitochondrial function.",
        "bel_statement": "p(HGNC:GAPDH) directlyIncreases p(HGNC:SIRT1, pmod(NO, Cys, 387), pmod(NO, Cys, 390))"
      },
      {
        "evidence": "Additionally, transnitrosylation of SIRT1 by GAPDH at C387 and C390 has been found to inhibit the activity of SIRT1 leading to decreased PGC1\u0003b1 transcriptional activity; PGC1\u0003b1 is an important regulator of metabolism and mitochondrial function.",
        "bel_statement": "p(HGNC:SIRT1, pmod(NO, Cys, 387), pmod(NO, Cys, 390)) decreases act(p(HGNC:SIRT1))"
      },
      {
        "evidence": "Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.",
        "bel_statement": "act(p(HGNC:SIRT1)) directlyDecreases p(HGNC:TP53, pmod(Ac, Lys))"
      }
    ]
  },
  {
    "Index": "12",
    "Result": [
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT1) association p(HGNC:SIRT1, loc(GO:nucleus))"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT6) association p(HGNC:SIRT6, loc(GO:nucleus))"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT7) association p(HGNC:SIRT7, loc(GO:nucleus))"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT2) association p(HGNC:SIRT2, loc(GO:cytoplasm))"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT3) association p(HGNC:SIRT3, loc(GO:mitochondrion))"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT4) association p(HGNC:SIRT4, loc(GO:mitochondrion))"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT5) association p(HGNC:SIRT5, loc(GO:mitochondrion))"
      },
      {
        "evidence": "This review will focus on SIRT1 (EC 3.5.1.-) a member of the sirtuin family that is expressed in many tissues and acts as a NAD+-dependent protein deacetylase.",
        "bel_statement": "a(CHEBI:\"NAD(+)\") increases act(p(HGNC:SIRT1))"
      },
      {
        "evidence": "SIRT1 has been implicated in signaling pathways underlying various diseases, including: diabetes, cardiovascular disease, neurodegeneration, cancer, aging, and obesity.",
        "bel_statement": "p(HGNC:SIRT1) increases bp(GO:\"signal transduction\")"
      }
    ]
  },
  {
    "Index": "13",
    "Result": [
      {
        "evidence": "NF-kappaB signaling exerts anti-apoptotic and cyto-protective properties, which is illustrated by many genetic in vivo models, in which deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).",
        "bel_statement": "act(a(FPLX:NFkappaB)) decreases bp(GO:\"apoptotic process\")"
      },
      {
        "evidence": "NF-kappaB signaling exerts anti-apoptotic and cyto-protective properties, which is illustrated by many genetic in vivo models, in which deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).",
        "bel_statement": "act(a(FPLX:NFkappaB)) decreases bp(GO:\"cell death\")"
      },
      {
        "evidence": "NF-kappaB signaling exerts anti-apoptotic and cyto-protective properties, which is illustrated by many genetic in vivo models, in which deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).",
        "bel_statement": "p(HGNC:MAP3K7) decreases bp(GO:\"cell death\")"
      },
      {
        "evidence": "NF-kappaB signaling exerts anti-apoptotic and cyto-protective properties, which is illustrated by many genetic in vivo models, in which deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).",
        "bel_statement": "p(HGNC:IKBKG) decreases bp(GO:\"cell death\")"
      },
      {
        "evidence": "This apoptosis in the absence of NF-kappaB depends on the persistent activation of the JNK axis followed by the production of reactive oxygen species (ROS) (Chen et al.,).",
        "bel_statement": "act(a(FPLX:JNK)) increases a(CHEBI:\"reactive oxygen species\")"
      },
      {
        "evidence": "This apoptosis in the absence of NF-kappaB depends on the persistent activation of the JNK axis followed by the production of reactive oxygen species (ROS) (Chen et al.,).",
        "bel_statement": "a(CHEBI:\"reactive oxygen species\") increases bp(GO:\"apoptotic process\")"
      },
      {
        "evidence": "Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,), suggesting the existence of intra-cellular decision making processes discriminating between cyto-protection via NF-kappaB and programmed cell death via JNK.",
        "bel_statement": "p(HGNC:TNF) increases a(FPLX:NFkappaB)"
      },
      {
        "evidence": "Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,), suggesting the existence of intra-cellular decision making processes discriminating between cyto-protection via NF-kappaB and programmed cell death via JNK.",
        "bel_statement": "p(HGNC:TNF) increases a(FPLX:JNK)"
      }
    ]
  },
  {
    "Index": "14",
    "Result": [
      {
        "evidence": "Biological functions of TNF and subsequent activation of the NF-kappaB signaling pathway are associated with inflammatory processes, hepatocyte proliferation in response to acute or chronic liver damage, as well as tumorigenesis (DiDonato et al.,).",
        "bel_statement": "p(HGNC:TNF) association bp(GO:\"hepatocyte proliferation\")"
      }
    ]
  },
  {
    "Index": "15",
    "Result": [
      {
        "evidence": "For example, A20 suppresses apoptotic JNK signaling in a TNF-dependent and independent manner via induction of ASK1 degradation (Won et al.,).",
        "bel_statement": "p(HGNC:TNFAIP3) decreases act(p(FPLX:JNK))"
      },
      {
        "evidence": "For example, A20 suppresses apoptotic JNK signaling in a TNF-dependent and independent manner via induction of ASK1 degradation (Won et al.,).",
        "bel_statement": "p(HGNC:TNFAIP3) decreases p(HGNC:MAP3K5)"
      },
      {
        "evidence": "For example, A20 suppresses apoptotic JNK signaling in a TNF-dependent and independent manner via induction of ASK1 degradation (Won et al.,).",
        "bel_statement": "p(HGNC:TNFAIP3) decreases bp(GO:\"apoptotic process\")"
      },
      {
        "evidence": "Since A20 is efficiently induced by TNF administration it is tempting to speculate that the loss of ASK1 might shift the cellular response from apoptosis to survival and proliferation.",
        "bel_statement": "p(HGNC:TNF) increases p(HGNC:TNFAIP3)"
      },
      {
        "evidence": "ASK1 can phosphorylate JNK and the physical interaction between A20 and ASK1 has been demonstrated (Tobiume et al.,; Won et al.,).",
        "bel_statement": "act(p(HGNC:MAP3K5)) directlyIncreases p(FPLX:JNK, pmod(Ph))"
      },
      {
        "evidence": "ASK1 can phosphorylate JNK and the physical interaction between A20 and ASK1 has been demonstrated (Tobiume et al.,; Won et al.,).",
        "bel_statement": "complex(p(HGNC:TNFAIP3), p(HGNC:MAP3K5))"
      },
      {
        "evidence": "We here showed that TNF affects the interaction between A20 and ASK1, which could explain the ASK1-dependent phosphorylation of JNK at specific periods after TNF administration.",
        "bel_statement": "p(HGNC:TNF) regulates complex(p(HGNC:TNFAIP3), p(HGNC:MAP3K5))"
      }
    ]
  },
  {
    "Index": "16",
    "Result": [
      {
        "evidence": "Once the C1 complex is bound to the cell surface, the proteases are activated and are able to cleave another complement protein, C4 into the anaphylatoxin C4a and C4b.",
        "bel_statement": "act(p(FPLX:C1)) directlyIncreases p(HGNC:C4A)"
      },
      {
        "evidence": "Once the C1 complex is bound to the cell surface, the proteases are activated and are able to cleave another complement protein, C4 into the anaphylatoxin C4a and C4b.",
        "bel_statement": "act(p(FPLX:C1)) directlyIncreases p(HGNC:C4B)"
      },
      {
        "evidence": "This cleavage causes a large conformational change in C4b, allowing it to covalently bind to cell surfaces and bind another complement protein, C2.",
        "bel_statement": "p(HGNC:C4B) directlyIncreases complex(p(HGNC:C4B), p(HGNC:C2))"
      },
      {
        "evidence": "C2 is then cleaved into the activation peptide, C2b, and the protease containing C2a.",
        "bel_statement": "complex(p(HGNC:C4B), p(HGNC:C2)) directlyIncreases act(p(HGNC:C2))"
      },
      {
        "evidence": "The complex of C4b and C2a (C4b2a) is a serine protease that specifically cleaves C3 into the anaphylatoxin C3a and the active form of C3, C3b, which is then able to covalently bind to the cell surfaces.",
        "bel_statement": "act(complex(p(HGNC:C4B), p(HGNC:C2))) directlyIncreases p(HGNC:C3)"
      }
    ]
  },
  {
    "Index": "17",
    "Result": [
      {
        "evidence": "For example, in the fluid phase, factor H can bind to C3b, preventing the formation of the C3 convertase.",
        "bel_statement": "complex(p(HGNC:CFH), p(HGNC:C3))"
      },
      {
        "evidence": "Once bound to see C3b, factor H serves as a co-factor, allowing another compliment protein, factor I, to cleave C3b, thus inactivating it.",
        "bel_statement": "p(HGNC:CFH) decreases p(HGNC:C3)"
      }
    ]
  },
  {
    "Index": "18",
    "Result": [
      {
        "evidence": "Injection of IgG, which also activates complement, into the paws of rats caused neuropathic pain symptoms.",
        "bel_statement": "act(complex(GO:\"IgG immunoglobulin complex\")) increases bp(GO:\"complement activation\")"
      }
    ]
  },
  {
    "Index": "19",
    "Result": [
      {
        "evidence": "Signaling lymphocytic activation molecule family 1 (SLAMF1) is an Ig-like receptor and a costimulatory molecule that initiates signal transduction networks in a variety of immune cells.",
        "bel_statement": "p(HGNC:SLAMF1) increases bp(GO:\"signal transduction\")"
      },
      {
        "evidence": "In this study, we report that SLAMF1 is required for Toll-like receptor 4 (TLR4)-mediated induction of interferon beta (IFNbeta) and for killing of Gram-negative bacteria by human macrophages.",
        "bel_statement": "p(HGNC:SLAMF1) increases act(p(HGNC:TLR4))"
      },
      {
        "evidence": "We found that SLAMF1 controls trafficking of the Toll receptor-associated molecule (TRAM) from the endocytic recycling compartment (ERC) to Escherichia coli phagosomes.",
        "bel_statement": "p(HGNC:SLAMF1) increases p(HGNC:TICAM2, loc(GO:\"phagocytic vesicle\"))"
      },
      {
        "evidence": "We found that SLAMF1 controls trafficking of the Toll receptor-associated molecule (TRAM) from the endocytic recycling compartment (ERC) to Escherichia coli phagosomes.",
        "bel_statement": "p(HGNC:SLAMF1) decreases p(HGNC:TICAM2, loc(GO:\"recycling endosome\"))"
      },
      {
        "evidence": "In resting macrophages, SLAMF1 is localized to ERC, but upon addition of E. coli, it is trafficked together with TRAM from ERC to E. coli phagosomes in a Rab11-dependent manner.",
        "bel_statement": "p(HGNC:SLAMF1) association p(HGNC:TICAM2)"
      },
      {
        "evidence": "We found that endogenous SLAMF1 protein interacted with TRAM and defined key interaction domains as amino acids 68 to 95 of TRAM as well as 15 C-terminal amino acids of SLAMF1.",
        "bel_statement": "complex(p(HGNC:SLAMF1), p(HGNC:TICAM2))"
      }
    ]
  },
  {
    "Index": "20",
    "Result": [
      {
        "evidence": "TLR4 recognizes lipopolysaccharide (LPS) from Gram-negative bacteria in complex with the coreceptors myeloid differentiation factor 2 and CD14, and it recruits signaling adapters myeloid differentiation primary response gene 88 (MyD88) and MyD88 adapter-like (Mal).",
        "bel_statement": "p(HGNC:TLR4) association a(CHEBI:lipopolysaccharide)"
      },
      {
        "evidence": "TLR4 recognizes lipopolysaccharide (LPS) from Gram-negative bacteria in complex with the coreceptors myeloid differentiation factor 2 and CD14, and it recruits signaling adapters myeloid differentiation primary response gene 88 (MyD88) and MyD88 adapter-like (Mal).",
        "bel_statement": "p(HGNC:TLR4) association p(HGNC:CD14)"
      },
      {
        "evidence": "TLR4 recognizes lipopolysaccharide (LPS) from Gram-negative bacteria in complex with the coreceptors myeloid differentiation factor 2 and CD14, and it recruits signaling adapters myeloid differentiation primary response gene 88 (MyD88) and MyD88 adapter-like (Mal).",
        "bel_statement": "p(HGNC:TLR4) directlyIncreases complex(p(HGNC:TLR4), p(HGNC:MYD88))"
      },
      {
        "evidence": "TLR4 recognizes lipopolysaccharide (LPS) from Gram-negative bacteria in complex with the coreceptors myeloid differentiation factor 2 and CD14, and it recruits signaling adapters myeloid differentiation primary response gene 88 (MyD88) and MyD88 adapter-like (Mal).",
        "bel_statement": "p(HGNC:TLR4) directlyIncreases complex(p(HGNC:TLR4), p(HGNC:MAL))"
      },
      {
        "evidence": "TLR4 is also present on endosomes and phagosomes to which the signaling adapter Toll receptor-associated molecule (TRAM) is recruited.",
        "bel_statement": "p(HGNC:TLR4, loc(GO:endosome)) directlyIncreases p(HGNC:TICAM2, loc(GO:endosome))"
      },
      {
        "evidence": "TLR4 is also present on endosomes and phagosomes to which the signaling adapter Toll receptor-associated molecule (TRAM) is recruited.",
        "bel_statement": "p(HGNC:TLR4, loc(GO:\"phagocytic vesicle\")) directlyIncreases p(HGNC:TICAM2, loc(GO:\"phagocytic vesicle\"))"
      },
      {
        "evidence": "The mechanism controlling TRAM recruitment remains unclear but seems to be Rab11 dependent.",
        "bel_statement": "p(HGNC:RAB11A) increases p(HGNC:TICAM2, loc(GO:endosome))"
      },
      {
        "evidence": "The mechanism controlling TRAM recruitment remains unclear but seems to be Rab11 dependent.",
        "bel_statement": "p(HGNC:RAB11A) increases p(HGNC:TICAM2, loc(GO:\"phagocytic vesicle\"))"
      }
    ]
  }
]